BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34954904)

  • 1. Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.
    Chan TC; Chen YT; Tan KT; Wu CL; Wu WJ; Li WM; Wang JM; Shiue YL; Li CF
    Clin Transl Med; 2021 Dec; 11(12):e674. PubMed ID: 34954904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological impacts of CEBPD on urothelial carcinoma development and progression.
    Chan TC; Shiue YL; Li CF
    Front Oncol; 2023; 13():1123776. PubMed ID: 36776299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.
    Chan TC; Hsing CH; Shiue YL; Huang SK; Hsieh KL; Kuo YH; Li CF
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.
    Wang YH; Wu WJ; Wang WJ; Huang HY; Li WM; Yeh BW; Wu TF; Shiue YL; Sheu JJ; Wang JM; Li CF
    Oncotarget; 2015 Oct; 6(31):31069-84. PubMed ID: 26307680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
    Wang WJ; Li CF; Chu YY; Wang YH; Hour TC; Yen CJ; Chang WC; Wang JM
    Clin Cancer Res; 2017 Jan; 23(2):503-513. PubMed ID: 27435393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEBPD suppresses prolactin expression and prolactinoma cell proliferation.
    Tong Y; Zhou J; Mizutani J; Fukuoka H; Ren SG; Gutierrez-Hartmann A; Koeffler HP; Melmed S
    Mol Endocrinol; 2011 Nov; 25(11):1880-91. PubMed ID: 21980073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases.
    Hansel DE; Swain E; Dreicer R; Tubbs RR
    Am J Clin Pathol; 2008 Aug; 130(2):274-81. PubMed ID: 18628098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation.
    Wang SM; Lin HY; Chen YL; Hsu TI; Chuang JY; Kao TJ; Ko CY
    J Neuroinflammation; 2019 Jul; 16(1):146. PubMed ID: 31300060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.
    Pan YC; Li CF; Ko CY; Pan MH; Chen PJ; Tseng JT; Wu WC; Chang WC; Huang AM; Sterneck E; Wang JM
    Clin Cancer Res; 2010 Dec; 16(23):5770-80. PubMed ID: 20971808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
    Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
    BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells.
    Hour TC; Lai YL; Kuan CI; Chou CK; Wang JM; Tu HY; Hu HT; Lin CS; Wu WJ; Pu YS; Sterneck E; Huang AM
    Biochem Pharmacol; 2010 Aug; 80(3):325-34. PubMed ID: 20385105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
    FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.
    Chuang CH; Wang WJ; Li CF; Ko CY; Chou YH; Chuu CP; Cheng TL; Wang JM
    Cell Death Dis; 2014 May; 5(5):e1220. PubMed ID: 24810056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
    Liu P; Cao W; Ma B; Li M; Chen K; Sideras K; Duitman JW; Sprengers D; Khe Tran TC; Ijzermans JNM; Biermann K; Verheij J; Spek CA; Kwekkeboom J; Pan Q; Peppelenbosch MP
    Carcinogenesis; 2019 Mar; 40(1):155-163. PubMed ID: 30325409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.
    Yang Y; Xia S; Zhang L; Wang W; Chen L; Zhan W
    Cancer Biol Ther; 2020 Jun; 21(6):522-532. PubMed ID: 32151175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.
    Chan TC; Wu WJ; Li WM; Shiao MS; Shiue YL; Li CF
    Theranostics; 2020; 10(25):11775-11793. PubMed ID: 33052246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma.
    Zeng Z; Wang J; Xu F; Hu P; Hu Y; Zhuo W; Chen D; Han S; Wang F; Zhao Y; Huang Y; Zhao G
    Int J Biol Sci; 2024; 20(5):1744-1762. PubMed ID: 38481809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/enhancer-binding protein delta mediates tumor necrosis factor alpha-induced Aurora kinase C transcription and promotes genomic instability.
    Wu SR; Li CF; Hung LY; Huang AM; Tseng JT; Tsou JH; Wang JM
    J Biol Chem; 2011 Aug; 286(33):28662-28670. PubMed ID: 21715338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of macrophage CCAAT/enhancer binding protein delta in the pathogenesis of rheumatoid arthritis in collagen-induced arthritic mice.
    Chang LH; Huang HS; Wu PT; Jou IM; Pan MH; Chang WC; Wang DD; Wang JM
    PLoS One; 2012; 7(9):e45378. PubMed ID: 23028973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.